Trademarkia Logo

Canada

C$
SECOND GENOME
CANCELLED

Last Applicant/ Owned by

GENEVIVE INC.

1548 Tarrytown StreetSan Mateo CA 94402

US

Serial Number

2025428 filed on 13th Mar 2020

Registration Number

TMA1151516 registered on 16th Nov 2022

Registration expiry Date

13th Mar 2030

SECOND GENOME

Trademark usage description

medical and veterinary therapeutic pharmaceutical for the treatment of metabolic, central nervous system, endocrine, musculoskeletal, cardiovascular, Read More

Classification Information


Class [005]
Medical and veterinary therapeutic pharmaceutical for the treatment of metabolic, central nervous system, endocrine, musculoskeletal, cardiovascular, degenerative nerve and bone diseases, neurodegenerative, oncological, neurological, gastrointestinal, developmental, hepatological, ophthalmic, respiratory, hormonal, dermatological, psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, chronic inflammatory and autoimmune related diseases and disorders in humans and animals.


Classification kind code

11

Mark Details


Serial Number

2025428

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 31st Aug 2021
Search Recorded
Submitted for opposition 20
on 31st Aug 2021
Examiner's First Report
Submitted for opposition 223
on 31st Aug 2021
Total Provisional Refusal
Submitted for opposition 48
on 30th Aug 2021
Agent Changed
Submitted for opposition 256
on 1st Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 30th Apr 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 29th Apr 2020
Created
Submitted for opposition 31
on 29th Apr 2020
Formalized
Submitted for opposition 30
on 13th Mar 2020
Filed
Submitted for opposition 228
on 13th Mar 2020
International Registration